InvestWiser

Omda AS

OMDAOslo BørsHealthcareMarket value 886 m NOK
43.20NOK −3.8%
last day · Price as of 18 November 2026

The answer first

Does Omda beat the market?

No, Omda has not beaten the market over the last year.

Omda−5.0%Oslo Børs (OSEBX)+32.3%
  • The ranking · Quality, value and trend combined

    Better than 19% of Nordic stocks

    • Quality4
    • Value13
    • Trend87

    No. 131 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash Omda keeps must grow about 18% a year for 10 years.

Max for seven days

Follow Omda with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Omda

From today, at a price of 43.20 NOK. Write why you follow Omda, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Omda

Your first answer is free, no account needed.

Do you own Omda, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Omda and a few more. Free, no card.

Past year against the exchange and Super Stock
Omda−5.0%Oslo Børs (OSEBX)+32.3%Super Stock+45.9%
12 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Omda has fallen 5.0% over the past year, including dividends.
  • Overall, Omda ranks better than 19% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 77.8%. The price is 56.5% below its peak now.

What do analysts think of Omda?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

19

Quality, value and trend together. Better than 19% of Nordic stocks.

No. 131 of 195 in healthcare

Quality4
The company · Fundamentals: the accounts

Low Weaker accounts than most: low profitability, high debt or uneven results.

No. 193 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity−24.24
  • Asset turnoverSales divided by everything the company owns0.69
  • Return on equityProfit divided by equity−158.8%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value13
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 123 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50

  • P/BPrice divided by equitynegative earnings
  • P/SPrice divided by sales1.9
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flow16.6

The ranking is built on P/E, P/B and P/S.

Trend87
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 30 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+24.4%
  • 6 months+30.5%
  • 9 months+9.8%
  • 12 months−5.0%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−6.1%
3 years, per year
+11.5%
5 years, per year
−11.9%
Year to date
−1.5%
Largest fall, 3 years
−77.8%
From a peak to the bottom
From the peak now
−56.5%
How far the price is from the peak
Volatility, 1 year
40.1%
How much the price swings over a year
Beta, 1 year
0.15
How much the price moves when the market moves

Return with dividends reinvested.

About Omda

Omda AS is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 250 employees.

Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution.

See the full analysis of Omda.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Oslo Børs

Explore the stock market